Some women with breast cancer are calling it quits with their aromatase inhibitor

June 2007

Some women with breast cancer are calling it quits with their aromatase inhibitor...Arimidex, Aromasin, and Femara.

Aromatase inhibitors work better than tamoxifen to prevent recurrence of estrogen-receptor positive breast cancer in postmenopausal women.

And they were initially thought to be better tolerated.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote